Join the Breakthrough Pain group to help and get support from people like you.
Breakthrough Pain News
Related terms: Pain, breakthrough
Self-Medicating With Weed Might Make Things Worse
FRIDAY, Sept. 5, 2025 — Folks who start using weed to cope with anxiety, depression or pain might end up with a worse mental state than before, a new study says. People self-medicating with marijuana ...
FDA Warns of Rising Injuries From Misuse of Laughing Gas
MONDAY, March 17, 2025 – Health officials are warning about a rise in injuries linked to the misuse of nitrous oxide, aka laughing gas. The gas, which is used medically as a sedative and in whipped...
Guidance Provided for Safe Use of Ketamine
TUESDAY, Feb. 25, 2025 – Administration of ketamine for purposes other than acute pain management and procedural sedation should be subject to the same prescribing guidelines as other sedating...
FDA Approves Journavx, First New Non-Opioid Pain Pill in Decades
FRIDAY, Jan. 31, 2025 – The U.S. Food and Drug Administration (FDA) has approved Journavx, a new pain reliever without the risks of addiction or overdose linked to drugs like Vicodin and OxyContin....
Reiki May Help Ease the Pain of Cancer Treatment
FRIDAY, Dec. 13, 2024 – The ancient Japanese practice of reiki "energy healing" might help some cancer patients deal with the pain that can come with infusion therapies, new research shows....
FDA Approves Lazanda - First Fentanyl Nasal Spray - for the Management of Breakthrough Pain in Cancer Patients
READING, England and BEDMINSTER, N.J., June 30, 2011 /PRNewswire/ – Archimedes Pharma Ltd., and its subsidiary, Archimedes Pharma U.S. Inc., today announced that the U.S. Food and Drug...
FDA Approval for Abstral (Fentanyl) Sublingual Tablets
Uppsala, January 10, 2011 - Orexo AB announces today that its partner ProStrakan Group plc has received approval from the US Food and Drug Administration (FDA) for Abstral. Abstral is licensed for...